OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Dermatology is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
银屑病皮肤细胞中的小分子 RNA 促进炎症发生	242
Correction	237
Adding up the desmosomal genes causing syndromes with hair and skin involvement: identification of TUFT1 by state-of-the-art whole-genome sequencing	156
Atypical melanocytes of an atypical Spitz tumour observed with optical super-high magnification dermoscopy	103
How to score the impact of treatment on cutaneous neurofibromas in clinical trials	101
Delusional infestation – do not be scared!	101
O11 The human discs large protein (Dlg1) controls connexin 43 (Cx43) plasma membrane localization and gap junctional communication in keratinocytes	89
O06 Exploring host–microbiome–immune interactions using singular and multispecies inoculations in optimized 3D skin models	86
Interactive effect of genetic and environmental risk factors on psoriasis: current evidence and future directives	78
Editor's Choice – John Ingram – Sep 2023	77
Issue Information	76
Higher proportion of cellulitis in severe lymphoedema	74
520 - Evaluating the expression of OX40 and OX40 ligand in lesional skin versus non-lesional skin in volunteers with atopic dermatitis and in healthy control skin	73
Greater understanding about differences in the long-term course of eczema and their risk factors in children	73
561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial	71
A guide to using the core outcome set for eczema	70
A current need for the use of improved and standardized outcome measures by clinical studies of pemphigus	70
Editor's Choice – John Ingram – December 2023	69
Risankizumab versus apremilast in the era of skin clearance	66
O22 Unravelling the pathophysiology of KLICK syndrome to identify therapeutically targetable pathways	66
Incidence, mortality and survival in people with Merkel cell carcinoma: a systematic review	64
Proliferative actinic keratoses are associated with adverse clinical outcomes relative to actinic keratoses without a proliferative growth pattern	60
Newborn genome screening (the Generation Study): the advent of presymptomatic diagnosis for genodermatoses	59
010 Enhanced outcome prediction in cutaneous squamous cell carcinoma using deep-learning and computational histopathology (cSCCnet)	57
CD03 Contact sensitization to shellac: a possible marker of fragrance allergy	57

P50 Exploring unmet needs and attitudes to skin self-examination in melanoma survivors: EUNASS study	56
P13 A rare case of Sjögren syndrome in a White woman with Kikuchi–Fujimoto disease	56
DP22 Cutaneous lymphoid hyperplasia: clinicopathological correlation and a therapeutic option	55
PA37 A retrospective review of the impact of virtual reality headsets in paediatric skin surgery	53
SG10 (P058) The epidemiology of epidermolysis bullosa in England, 1997–2024: a retrospective national cohort study	52
CPC02 Delayed widespread lichenoid drug reaction with radioisotopic response in a patient treated with nivolumab	51
P67 Overall lifetime risk for alopecia areata is 2.1% and is higher in women, non-White ethnic groups and the most deprived: a UK population-based cohort study	51
P068 Oral tofacitinib in comparison with dexamethasone oral mini-pulse therapy for the treatment of active nonsegmental vitiligo: a randomized controlled trial	51
730 - Patient opinions on healthcare provider interactions and current treatment satisfaction in adults with atopic dermatitis by race and ethnicity	51
P74 Guselkumab clinical super-response is associated with faster normalization of blood and skin pathology: data from the Phase 3b GUIDE trial	51
PA24 Abnormal interferon signature in a patient with chilblain lupus	50
BH08 Unprovoked pulmonary emboli in a patient with alopecia areata treated with ritlecitinib: a case report	50
603 - Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2–11 years: 52 week results from a maximum-use trial	47
DP21 Thymoma and the skin: manifestations of multiorgan autoimmunity	46
BH18 A rare case of nail sarcoidosis presenting as an ulcerated nail tumour in a Afro-Caribbean patient	46
BI26 Treatment-induced scleroderma in a patient with metastatic melanoma	46
677 - Establishing a patient-centered definition of atopic dermatitis flare: insights from a modified eDelphi study	46
335 Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment	46
643 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of short-term (week 8-20) data from a real-world multicenter retrospective review	45
673 - Efficacy of nemolizumab in different subgroups of patients with prurigo nodularis in two randomized, placebo-controlled phase 3 trials	45
P19 The association between psoriatic disease severity and adherence to the Mediterranean diet: a systematic review of observational studies	45
691 - Understanding patient and physician preferences when choosing between biologic and oral systemic treatment options for moderate-to-severe atopic dermatitis: a discrete choice experiment	45